EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The ERA Registry Annual Report 2021: a summary

Brittany A Boerstra iD, Rianne Boenink, Megan E Astley, Marjolein Bonthuis, Samar Abd ElHafeez, Federico Arribas Monzón, Anders Åsberg, Pazit Beckerman, Samira Bell iD, Aleix Cases Amenós iD, Pablo Castro de la Nuez, Marc A G J Ten Dam und 32 weitere

Clinical Kidney Journal · 01.02.2024 · 17 (2)

DOI: 10.1093/ckj/sfad281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 15.11.2023. Verfasst von Brittany A Boerstra und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Renal Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The European Renal Association (ERA) Registry collects data on kidney replacement therapy (KRT) in patients with end-stage kidney disease (ESKD). This paper is a summary of the ERA Registry Annual Report 2021, including a comparison across treatment modalities.

Methods

Data was collected from 54 national and regional registries from 36 countries, of which 35 registries from 18 countries contributed individual patient data and 19 registries from 19 countries contributed aggregated data. Using this data, incidence and prevalence of KRT, kidney transplantation rates, survival probabilities and expected remaining lifetimes were calculated.

Result

In 2021, 533.2 million people in the general population were covered by the ERA Registry. The incidence of KRT was 145 per million population (pmp). In incident patients, 55% were 65 years or older, 64% were male, and the most common primary renal disease (PRD) was diabetes (22%). The prevalence of KRT was 1040 pmp. In prevalent patients, 47% were 65 years or older, 62% were male, and the most common PRDs were diabetes and glomerulonephritis/sclerosis (both 16%). On 31 December 2021, 56% of patients received haemodialysis, 5% received peritoneal dialysis, and 39% were living with a functioning graft. The kidney transplantation rate in 2021 was 37 pmp, a majority coming from deceased donors (66%). For patients initiating KRT between 2012–2016, 5-year survival probability was 52%. Compared to the general population, life expectancy was 65% and 68% shorter for males and females receiving dialysis, and 40% and 43% shorter for males and females living with a functioning graft.

Schlagwörter

Stichwörter der Autor:innen

ESKDdialysisgraft survivalkidney transplantationpatient survival

Autor:innen und Institutionen

  • Department of Medical Informatics, University of Amsterdam, ERA Registry, Amsterdam UMC, Amsterdam, The Netherlands.
  • Amsterdam Public Health, Health Behaviours & Chronic Diseases, Amsterdam, The Netherlands.
  • Amsterdam Public Health, Ageing & Later Life, Amsterdam, The Netherlands.
  • Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands.
  • Amsterdam Public Health, Global Health, Amsterdam, The Netherlands.
  • Amsterdam Public Health, Methodology, Amsterdam, The Netherlands.

ORCID-Profile: Brittany A Boerstra, Samira Bell, Aleix Cases Amenós, Julia Kerschbaum, Nurhan Seyahi, Alberto Ortiz, Kitty J Jager, Anneke Kramer

Förderung

  • European Renal Association

Zitieren

APA

Boerstra, B. A., Boenink, R., Astley, M. E., Bonthuis, M., Abd ElHafeez, S., Arribas Monzón, F., Åsberg, A., Beckerman, P., Bell, S., Cases Amenós, A., Castro de la Nuez, P., Ten Dam, M. A. G. J., Debska-Slizien, A., Gjorgjievski, N., Giudotti, R., Helve, J., Hommel, K., Idrizi, A., Indriðason, Ó. S., …, & Kramer, A. (2024). The ERA Registry Annual Report 2021: a summary. Clinical Kidney Journal, 17(2). https://doi.org/10.1093/ckj/sfad281

Vancouver

Boerstra BA, Boenink R, Astley ME, Bonthuis M, Abd ElHafeez S, Arribas Monzón F, et al. The ERA Registry Annual Report 2021: a summary. Clinical Kidney Journal. 2024;17(2). doi:10.1093/ckj/sfad281

BibTeX
@article{Boerstra2024,
  author = {Boerstra, Brittany A and Boenink, Rianne and Astley, Megan E and Bonthuis, Marjolein and Abd ElHafeez, Samar and Arribas Monzón, Federico and Åsberg, Anders and Beckerman, Pazit and Bell, Samira and Cases Amenós, Aleix and Castro de la Nuez, Pablo and Ten Dam, Marc A G J and Debska-Slizien, Alicja and Gjorgjievski, Nikola and Giudotti, Rebecca and Helve, Jaakko and Hommel, Kristine and Idrizi, Alma and Indriðason, Ólafur S and Jarraya, Faiçal and Kerschbaum, Julia and Komissarov, Kirill S and Kozliuk, Nadiia and Kravljaca, Milica and Lassalle, Mathilde and De Meester, Johan M and Ots-Rosenberg, Mai and Plummer, Zoe and Radunovic, Danilo and Razvazhaieva, Olena and Resic, Halima and Rodríguez Arévalo, Olga Lucía and Santiuste de Pablos, Carmen and Seyahi, Nurhan and Slon-Roblero, María Fernanda and Stendahl, Maria and Tolaj-Avdiu, Miloreta and Trujillo-Alemán, Sara and Ziedina, Ieva and Ziginskiene, Edita and Ortiz, Alberto and Jager, Kitty J and Stel, Vianda S and Kramer, Anneke},
  title = {The ERA Registry Annual Report 2021: a summary},
  journal = {Clinical Kidney Journal},
  year = {2024},
  volume = {17},
  number = {2},
  doi = {10.1093/ckj/sfad281}
}
Kostenlos starten →